Experience

European Cancer Patient Coalition
• Belgium
• Hospitals and Health Care
• 1 - 100 Employee
• Senior Health and Research Officer

  • May 2023 - Present


Vrije Universiteit Brussel

• Belgium
• Research Services
• 700 & Above Employee

• Postdoctoral Fellow

  • Feb 2018 - Apr 2022

  Follicle Biology Lab Marie Skłodowska-Curie fellow Designed & leaded a project funded by Marie Skłodowska-Curie Actions focused on the molecular characterization of polycystic ovary syndrome. Assessed the epigenetic safety of assisted reproductive techniques & identified technique-associated biomarkers. Follicle Biology Lab Marie Skłodowska-Curie fellow Designed & leaded a project funded by Marie Skłodowska-Curie Actions focused on the molecular characterization of polycystic ovary syndrome. Assessed the epigenetic safety of assisted reproductive techniques & identified technique-associated biomarkers.



Rockefeller University

• United States
• Medical Practices
• 1 - 100 Employee

• Postdoctoral Associate

  • Nov 2015 - Nov 2017

  Laboratory for Pediatric Brain Disease Investigated the impact of Zika virus infection in the central nervous system. Laboratory for Pediatric Brain Disease Investigated the impact of Zika virus infection in the central nervous system.



Icahn School of Medicine at Mount Sinai

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Postdoctoral Fellow

  • Apr 2014 - Nov 2015

  Pathology and Oncological Sciences department Collaborated in the identification and validation of novel actionable targets in breast cancer. Pathology and Oncological Sciences department Collaborated in the identification and validation of novel actionable targets in breast cancer.



CNIO (Spanish National Cancer Research Centre)

• Spain
• Research Services
• 300 - 400 Employee

• Predoctoral Fellow

  • Feb 2008 - Jan 2014

  Human Genetics Group Investigated the involvement of CUL4A oncogene in aggressiveness and progression in primary breast tumors. Human Genetics Group Investigated the involvement of CUL4A oncogene in aggressiveness and progression in primary breast tumors.